EUVIMEDScopri EUVIMED
Open access · CC BY 4.0

Somatic Evolution of a Germline Antibody Expands its Breadth to Neutralize Early SARS‐CoV‐2 Omicron Variants

Huibin Lv iD, Ziqi Feng, Qi Wen Teo, Chunke Chen, Akshita B Gopal, Danbi Choi, Timothy J C Tan, Yun Sang Tang, Lewis Siu, Armita Nourmohammad, Roberto Bruzzone, Ian A Wilson and 3 more

Advanced Science · 2026-07-13

DOI: 10.1002/advs.76522 ↗

At a glance

Journal article in Advanced Science, published online on 2026-07-13. Written by Huibin Lv and 14 co-authors. Institution: Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA. Cited 1 times so far (Crossref); 60 references. The full text is freely available (open access, CC BY 4.0). Funded by: Calmette and Yersin scholarship from the Pasteur International Network Association, Carl R. Woese Institute for Genomic Biology (IGB) postdoctoral fellowship, Research Grants Council of the Hong Kong Special Administrative Region, China.

AbstractDati bibliograficiCiteRelated studies

Abstract (original language)

Rapid antigenic drift of the SARS‐CoV‐2 receptor‐binding domain (RBD) underlies immune escape and continues to challenge the durability of antibody‐mediated protection. Among the major classes of RBD‐directed antibodies, germline‐encoded IGHV3‐53 responses are highly potent against early SARS‐CoV‐2 variants but are generally compromised by Omicron‐associated mutations. Here, we identify an intrinsically cross‐reactive IGHV3‐53 germline antibody that recognizes multiple pre‐Omicron variants, including SARS‐CoV‐2 wild‐type, Alpha, and Delta. Notably, we demonstrate that targeted somatic evolution can further expand this breadth to overcome the immune escape of different Omicron variants. Guided by integrated structural and sequence analyses, we introduce four somatic mutations (G26E, T28I, S53P, and Y58F) into the germline antibody, resulting in markedly enhanced binding and neutralization of Omicron BA.1, and BA.4/5. High‐resolution crystal structures reveal that these mutations re‐establish interactions disrupted by substitutions in the Omicron RBD and improve binding at a remodeled epitope interface. Collectively, our findings define the structural basis by which specific mutations enhance cross‐variant recognition of SARS‐CoV‐2. This work highlights the underappreciated breadth encoded within the naïve B‐cell repertoire and provides a conceptual framework for engineering and eliciting antibody responses resilient to future antigenic drift.

Authors and institutions

  • Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.
  • Department of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.
  • HKU-Pasteur Research Pole, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
  • Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, USA.
  • The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong SAR, China.
  • Li Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.

ORCID profiles: Huibin Lv

Funding

  • Calmette and Yersin scholarship from the Pasteur International Network Association
  • Carl R. Woese Institute for Genomic Biology (IGB) postdoctoral fellowship
  • Research Grants Council of the Hong Kong Special Administrative Region, China
  • Health and Medical Research Fund
  • Vallee Scholars Program
  • Searle Scholars Program
  • Howard Hughes Medical Institute Emerging Pathogens Initiative

Cite

APA

Lv, H., Feng, Z., Teo, Q. W., Chen, C., Gopal, A. B., Choi, D., Tan, T. J. C., Tang, Y. S., Siu, L., Nourmohammad, A., Bruzzone, R., Wilson, I. A., Yuan, M., Wu, N. C., & Mok, C. K. P. (2026). Somatic Evolution of a Germline Antibody Expands its Breadth to Neutralize Early SARS‐CoV‐2 Omicron Variants. Advanced Science. https://doi.org/10.1002/advs.76522

Vancouver

Lv H, Feng Z, Teo QW, Chen C, Gopal AB, Choi D, et al. Somatic Evolution of a Germline Antibody Expands its Breadth to Neutralize Early SARS‐CoV‐2 Omicron Variants. Advanced Science. 2026. doi:10.1002/advs.76522

BibTeX
@article{Lv2026,
  author = {Lv, Huibin and Feng, Ziqi and Teo, Qi Wen and Chen, Chunke and Gopal, Akshita B and Choi, Danbi and Tan, Timothy J C and Tang, Yun Sang and Siu, Lewis and Nourmohammad, Armita and Bruzzone, Roberto and Wilson, Ian A and Yuan, Meng and Wu, Nicholas C and Mok, Chris K P},
  title = {Somatic Evolution of a Germline Antibody Expands its Breadth to Neutralize Early SARS‐CoV‐2 Omicron Variants},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.76522}
}
Start for free →